New Life Medical
The etiology of NAD+ dysregulation remarkably coincides with the cascades postulated for the etiology of diabetic complications and other abnormalities induced by redox change.
Regenerative solutions and new tissue- engineering based strategies are promising for treatment of moderate OA.
HBOT can improve dysexecutive functions, psychiatric symptoms (depression, anxiety and somatisation), pain interference symptoms and fatigue of patients suffering from post-COVID condition.
Scientists in Israel have shown that a type of oxygen therapy can stop new plaques forming and even remove existing plaques in mice with Alzheimer’s.
A new approach to spinal cord stimulation may drastically reduce chronic back pain, a small pilot study suggests.
Spinal cord stimulation has seen unprecedented growth in new technology in the 50 years since the first subdural implant. As we continue to grow our understanding of spinal cord stimulation and relevant mechanisms of action, novel questions arise as to electrical dosing optimization.
Find Out How Global Neuromodulation in Epilepsy Market Helps The Research and Development Process. Find The Overview and Its Impact in the Future Key Players: Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, Medtronic, NeuroPace.
Neuromodulation is a fast-growing discipline that involves using targeted electrical, magnetic, mechanical, or thermal stimulation of the nervous system to change firing neuronal and interneuronal connection features to treat various neurological diseases.
Neurofeedback works by hooking patients up to a computer with electroencephalogram electrodes placed on a patient’s scalp that detect electrical activity in their brain.
The anesthesia medication ketamine is showing increased promise as a treatment for people experiencing depression who haven't found relief with other prescription medications.
